A flurry of laws passed by the Nevada Legislature earlier this year took effect on Friday – ushering in reforms that Democratic lawmakers who have majorities in both the state Senate and Assembly have long campaigned to implement.
Five years after the the state’s voters approved legalizing recreational cannabis in Nevada, business owners can now apply for licenses to establish on-site consumption lounges, where adults can smoke, dab or eat THC-laced edibles that they buy.
© 420 Intel
Sacramento-based financial technology software company NatureTrak Inc. has signed up a bank in New Mexico to use its tracking software to validate cannabis-related business deposits. It is the first bank to use the product, but several more banks are in the pipeline, with another expected to sign a contract next week, said Jontae James, CEO and founder of NatureTrak, via text. "The cannabis industry is exploding, and will continue to do so, as more and more states legalize medical and adult-use cannabis,” James said, in a news release.
NatureTrak developed an accounting and tracking system for financial institutions to be able to create an auditable supply chain record for their legal cannabis business customers. It has been used by North Bay Credit Union of Santa Rosa to validate more than $2 billion in cannabis-related transactions, including over $700 million in cash deposits and more than $250 million in tax payments, NatureTrak said.
The new bank customer is Southwest Capital Bank, a 131-year-old bank based in Albuquerque, New Mexico, with six branches. The bank had assets of $414.9 million as of June 30, according to the Federal Deposit Insurance Corp.
California legalized adult-use recreational marijuana in 2018, and New Mexico legalized it this year. However, under federal law, marijuana is still illegal, so banks, credit unions and brokerages — all of which have federal oversight — are at risk of losing their licenses to operate if they take money directly associated with cannabis without a rigorous audit trail.
NatureTrak’s platform accesses licenses in state and local databases and checks that they are valid for the transactions being done. It also creates receipts along the way from grower to processor to distributor and eventually sales. All those receipts, in turn, are meant to create an audit trail that can make more financial institutions comfortable in banking cannabis-related businesses, which otherwise are locked out of the financial system because recreational cannabis is still illegal under federal law. NatureTrak is paid by the bank or credit union for its software. All the tracking, verification and record-keeping gives a provenance to the money, which could allay the federal government's primary concern about money laundering.
© 420 Intel
The cannabis market made huge progress over the last several years. The increase in the number of users boosted the industry’s value. Thanks to premium platforms like Askgrowers.com, anyone interested can learn about cannabis strains and brands quickly. Even most governments seem readier than ever to adjust the laws and legalize cannabis. (As originally Seen on Benzinga)
© 420 Intel
An eight-year-old Woodstock child ate a large quantity of cannabis gummies over the weekend. The child was rushed to hospital and was in stable condition. Woodstock police wanted to remind people who consume cannabis, particularly edibles such as gummies or other sweets, to be mindful of safe storage away from children. Police encourage adults to safely store any alcohol and cannabis products out of reach or behind locked doors to ensure children do not consume them by mistake.
In the summer of 2020, Health Canada issued an advisory that children are being harmed after consuming illegal cannabis edibles that are not subject to safety and quality controls, do not have childproof packaging and have been stored by parents in places too easily accessible to kids. The caution was issued following several cases of children having been hospitalized after ingesting illegal weed edibles that looked like regular candies or treats.
© 420 Intel
Cannabis, also known as weed or marijuana, is used by hundreds of millions of people worldwide. Although restricted in most countries, the increasing legalization of cannabis for recreational and medicinal consumption means that cannabis use is rising. Cannabis is also the most common illicit drug used by pregnant women, but the effects of cannabis on embryonic development are not well understood. It is also important to understand the effects of cannabis on individuals with a genetic predisposition, which means they carry genetic mutations that increase the risk of environmental conditions triggering a defect or disease.
A new study from scientists at the Icahn School of Medicine at Mount Sinai, USA, has now revealed that THC, the chemical in cannabis that causes the sensation of feeling ‘high’, can cause birth defects in genetically predisposed mice. In this case, the researchers investigated whether THC could exacerbate a mutation that affects a mechanism that cells use to communicate with each other, called Hedgehog signaling. “Several years ago, it was reported that THC could inhibit Hedgehog signaling in cells grown in a dish,” said the study’s lead author Robert Krauss, PhD, Professor of Cell, Developmental and Regenerative Biology at the Icahn School of Medicine at Mount Sinai. “We reasoned that THC might be an environmental risk factor for birth defects, but that it would require additional risk factors, such as specific mutations in the genes required for Hedgehog signaling, to induce these defects in mice.”
To address this hypothesis, Dr. Krauss and colleagues administered a single dose of THC, equivalent to exposures achieved when humans smoke cannabis, to pregnant mice about a week after conception. They then studied the embryonic development of their pups, some of which carried a mutation that meant Hedgehog signaling was not functioning at full efficiency. The scientists found that pups without the mutation developed normally, even when exposed to THC, as did pups that carried the mutation but were not exposed to the drug. However, pups that were exposed to THC and carried the mutation developed a brain and face defect called holoprosencephaly, a common birth defect seen in 1 in 250 human conceptions that includes the failure of the forebrain to divide into two distinct segments.
These first studies in mice have important implications for human health, highlighting the need for more research into the effects of cannabis use during pregnancy in humans. “The THC concentration in cannabis is now very high, so it is important to perform epidemiology studies looking at whether cannabis consumption is associated with developmental defects. Women are already advised not to consume cannabis while pregnant, but our results show that embryos are sensitive at a very early period, before many women know they are pregnant. Cannabis consumption may therefore be inadvisable even when women are trying to get pregnant,” Dr. Krauss warned.
Although this study focussed on one chemical in cannabis and one genetic mutation, further research could reveal other combinations that cause similar effects. “Many of the mutations found in human holoprosencephaly patients could conceivably synergize with THC,” said Dr. Krauss. “We would also like to test the related chemical CBD in genetically predisposed mice. Like THC, CBD inhibits Hedgehog signaling in cells grown in a dish, but CBD appears to work differently. As CBD is widely available and often viewed as beneficial – or at least innocuous – it would be worth investigating this as well,” he added.
© 420 Intel
Trulieve, the state’s largest medical marijuana operator, is now the nation’s biggest cannabis retailer, after closing on a $2.1 billion deal to acquire former competitor Harvest Health & Recreation Inc.
The transaction marks a major development in Florida, where Harvest held one of 22 licenses to cultivate, process and sell medical marijuana to a growing patient population, and in the nation’s rapidly expanding pot industry.
Trulieve CEO Kim Rivers called the closing of the deal a “transformational milestone” in her Gadsden County-based company’s brief history.
© 420 Intel
CBD Oracle (Tustin, CA), a cannabis review and news site, has published an analysis of 520 CBD companies, representing over 20,000 products. The study sought to uncover issues with transparency in the unregulated CBD marketplace, which can threaten consumer trust. According to a survey from Consumer Brands Association, 92% of American consumers either incorrectly assume or have no idea if CBD is federally regulated. Upon being informed that there are no federal agencies that regulate CBD products, 84% of respondents expressed concern about the safety of CBD products.
CBD Oracle’s study offers an optimistic view of the industry. According to its findings, 89.4% of companies test their CBD products through accredited third-party labs, demonstrating a transparent industry. “Despite consumer apprehension being a huge problem, our analysis suggests an industry so conscious of its regulatory shortcomings it’s taking appropriate steps to fix them,” said Alisdair Mans Cornwell, senior editor at CBD Oracle, in a statement.
Additional findings showed that 89% of companies fully disclose their hemp source and cultivation practices. Most of U.S. hemp sourced for CBD products came from Colorado (30.1%), followed by Oregon (13.4%), then Kentucky and California (tied for 5.1%). Eight percent of hemp was source from Europe, according to the study. The most popular European sources of hemp were Holland, Lithuania, Switzerland, and Spain.
When it came to the most common type of CBD products offered, the majority of companies (72%) sell some type of CBD tincture. The second most popular option sold was topical CBD, offered by 65% of the companies in the analysis. The third and fourth most popular options were capsules and gummies, sold by 42% and 40% of companies, respectively. Unfortunately, 43% of CBD companies in the study did not disclose extraction methods used for their products. Of those that did disclose extraction methods, CO2 extraction was used by 42% of CBD companies, with ethanol extraction being the second most popular method (11%).
CBD Oracle also collected data about minor cannabinoids. According to its analysis, the most popular minor cannabinoid present in the marketplace is cannabigerol (CBG), sold by 20% of the 520 companies. This was followed by cannabinol (CBN), sold by 12% of the companies, and delta-8 THC, sold by 10% of the companies. CBD Oracle expected more companies to sell delta-8 THC. It cites data from New Fronteir Data that states sales of delta-8 THC has reached $10 million across the U.S. in 2020. Despite the exponential market growth of delta-8, CBD Oracle believes that restrictions on the sale of the minor cannabinoid across 19 states is likely contributing to relatively low adoption of delta-8 by manufacturers.
© 420 Intel
Unlicensed cannabis is not as strong as you may think it is.
That's according to a recently published study by the New Brunswick Research and Productivity Council.
Researchers comparing samples of illicit and legal cannabis products found that the claims of potency for illicit products were significantly less accurate.
The RPC's chief officer of science Diane Botelho said the study was taken on to find out whether there was any legitimacy to claims made about cannabis products on the illicit market being 'better'.
"Our scientists have been curious for a number of years now as to whether or not illicit cannabis products were equivalent to legal cannabis products with respect to health and safety as well as potency claims," said Botelho.
© 420 Intel
© 420 Intel
Following 11 months of collaborative dialogue, the Santa Barbara County Coalition for Responsible Cannabis (Coalition) and CARP Growers reached a historic agreement on Aug. 20, ensuring cannabis farms work in cooperation with the community group to resolve odor issues in a proactive and cooperative way across Carpinteria Valley.
The agreement holds all CARP Growers member farms accountable to a partnership with the coalition and a detailed odor abatement plan outlining a new expanded odor response process, and a comprehensive program to develop and implement next-generation odor technologies.
Community engagement in the plan will be encouraged for reporting, investigating, and resolving cannabis odor incidents.
© 420 Intel
Today, the Cannabis Freedom Alliance (CFA) added a new class of membership, Values Members, who share a vision with CFA of ending prohibition in a manner consistent with helping all Americans achieve their full potential and limiting the number of barriers that inhibit innovation and entrepreneurship in a free and open market; and three new working groups focused on CFA’s core values: Successful Second Chances and Competitive Open Markets.
CFA congratulates, and is proud to welcome, the newest additions to the coalition: Consumer Choice Center (CCC), End It For Good (EFIG), Nevada Policy (NP), R Street Institute (RSI), and Students for Liberty (SFL).
CFA is further proud to announce the creation of its three working groups:
Criminal Justice Reform and Successful Second Chances Working Group. This group seeks to advance policy changes that facilitate second chances for non-violent cannabis offenders through developing and socializing model policy around justice reform. In addition, the group will work to help secure clemency, commutation, pardons and the like for current non-violent cannabis offenders, as well as petitioning the White House for broader action on such clemency. This group will find ways to support former cannabis offenders in their reentry into society. This working group will be coordinated by former cannabis offender and second-chances advocate Weldon Angelos, Mission Green; and retired law enforcement officer Lt. Diane Goldstein, LEAP.
Federal Competitive and Entrepreneurial Markets Working Group. This group will help craft recommendations and produce policy papers, alongside allied organizations (subject to Steering Committee editing and approval) for CFA on promoting a free, vibrant and low-barriers cannabis market, and structuring tax policy on the federal and state level for maximal competitiveness, as we look towards interstate and international markets. This group will be coordinated by Ted Ellis, Director of Coalitions, AFP.State Competitive and Entrepreneurial Markets Working Group. This group will help craft recommendations and produce policy papers, alongside allied organizations (subject to Steering Committee editing and approval) for CFA on promoting a free, vibrant and low-barriers cannabis market, and structuring tax policy on the federal and state level for maximal competitiveness, with respect to state and intrastate marketplaces. This group will be coordinated by Spence Purnell of the Reason Foundation.Weldon Angelos, co-Coordinator of CFA’s Steering Committee said, “We are very pleased to have so many organizations joining our mission to end the injustices of prohibition and reforming the policies that incarcerated so many individuals unfairly.”
© 420 Intel
A former federal law enforcement officer turned Pennsylvania lawmaker became the second Republican state senator to publicly endorse legalizing recreational marijuana in the Keystone State.
York County state Sen. Mike Regan, the chairman of the Senate Law and Justice Committee, circulated a co-sponsorship memo late Monday to colleagues soliciting support for a bill to legalize marijuana for those 21 and older.
He said the revenue could be used to fund police, fight violent crime in cities and pay for afterschool programs in disadvantaged neighborhoods.
“Our law enforcement agencies and justice system do not have the manpower or time to handle these minor marijuana offenses that clog our courts and produce little return,” he wrote.
“Instead, police and prosecutors need to focus on protecting our residents from the violent criminals and large-scale drug importers that are also dealing in heroin and fentanyl, which kill thousands of Pennsylvanians each year.”
© 420 Intel
It’s not always easy to tell when your feline is stressed, but cats can be as anxiety-prone as people. Additionally, many aging cats start to experience joint pain and overall discomfort caused by conditions such as arthritis.
CBD products can offer a plethora of benefits to your furry friend. If you're looking for a great CBD product to soothe your cat, Cornbread CBD Oil for Pets works excellently for calming anxious behaviors. What to know before you buy CBD for cats
Many humans have begun turning to CBD to relieve joint and back pain, anxiety, sleeplessness and various inflammatory issues. As such, it isn't surprising that the market for pets has grown significantly. There aren't many conclusive studies about the effects of CBD, but one 2016 Israeli study linked CBD oil to a decrease in seizure frequency for children. Animals can be prone to seizures too, so the study bodes well for epileptic pets.
CBD for cats can treat a number of physical and emotional conditions. Inflammatory conditions like arthritis can be eased with CBD. The same may be true for cats with seizures and cats recovering from surgical procedures. CBD can even work for digestive issues, as it can reduce swelling in a cat’s digestive tract and improve overall discomfort. CBD is equally as popular for treating behavioral issues, the two major ones being anxiety and aggression. Since CBD interacts with endocannabinoids, which affect mood, CBD can help regulate and stabilize mood.
© 420 Intel
If you're looking for stocks that you can buy and hold for many years, it's important to choose companies with high-quality businesses and strong catalysts for growth. One industry that receives ample attention from investors of all ages and trading styles is the marijuana sector.
As more states have legalized pot for medical and recreational purposes, growers, retailers, and ancillary providers have popped up right and left. Legal cannabis sales in the U.S. shot up nearly 50% in 2020. And the global legal marijuana market is on track to reach a valuation of nearly $71 billion as soon as 2028.
© 420 Intel
American Cannabis Company, Inc.
(OTCQB: AMMJ) (“ACC” or “Company”), a full-service business-to-business cannabis and hemp
consulting solutions provider and licensed owner operator, is pleased to announce that its
proprietary potting mix, SoHum Living Soils®, was recently awarded an official certification from
the Organic Materials Review Institute (OMRI).
OMRI's mission is to provide the agricultural industry with peace of mind in knowing that
quality materials are consistent and organic as a standard. This organization provided an
independent review of SoHum Living Soils®, looking at each individual input that is intended for
use in certified organic cultivation and production.
© 420 Intel
According to a research study published by the University Of New Mexico and Releaf App in the Yale Journal of Biology and Medicine, cannabis flower may be effective in providing immediate relief for the symptoms of depression — a condition affecting roughly 1 in 5 adults in the U.S., and often leading to other ailments like cancer, substance use disorders, anxiety disorders, schizophrenia, dementia, diabetes, cardiovascular disease, and chronic pain. “The findings suggest that, at least in the short term, the vast majority of patients that use cannabis experience antidepressant effects, although the magnitude of the effect and extent of side effect experiences vary with chemotypic properties of the plant,” the paper reads.
The study, titled “The Effectiveness of Cannabis Flower for Immediate Relief from Symptoms of Depression,” was led by the founders of University of New Mexico’s Marijuana Research Fund, Jacob Vigil, Psychology Associate Professor at UNM, and Sarah See Stith, Economics Assistant Professor at UNM.
After reviewing 5,876 outcomes reported anonymously by 1,819 individuals tracking their cannabis use for treating depression through the Releaf App, the researchers concluded that, on average, patients reported an improvement in symptoms of nearly 4 points on a scale of 0 to 10, just moments after consuming whole, dried, natural cannabis flower – widely known as cannabis buds.
“One of the more interesting findings from this study is that cannabis flower with relatively high levels of tetrahydrocannabinol or THC is particularly associated with immediate reductions in the intensity of depressive feelings,” said Jacob Miguel Vigil. “The differences in time-to-effect and relative side effect prevalence across products and users could arise from other antidepressant and synergistic compounds in the plant beyond THC or cannabidiol (CBD), including minor cannabinoids, terpenes and flavonoids.”
Per the study, most of the patients using natural cannabis flower products to treat their depression symptoms reported antidepressant effects. However, the magnitude of these effects and extent of experienced side effects varied alongside the properties of each plant.
© 420 Intel
More and more states are beginning to implement legislation to regulate cannabis products. As sales of such products are becoming more prevalent, new and important regulations are expected to be implemented. One of the major concerns over cannabis abuse revolves around operating a vehicle while impaired. Generally, law enforcement officers may conduct field tests such as sobriety tests or even sample tests. However, sobriety tests can be inaccurate, while sample tests may not receive results for days or even weeks. As a result, companies within the cannabis marketspace began to develop the necessary technology for law enforcement agencies to use in crackdowns on drivers operating a vehicle while under the influence of marijuana. Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), OrganiGram Holdings Inc. (NASDAQ: OGI), HEXO Corp. (NYSE: HEXO), Cronos Group Inc. (NASDAQ: CRON), Aurora Cannabis Inc. (NASDAQ: ACB)
Presently, the medical cannabis sector accounts for a majority of the market share, as progress is slowly being made in removing the stigmas associated with such products. Overall, the legal cannabis market is permeating throughout the U.S. states and is helping to create a multi-billion-dollar industry. While medical cannabis still dominates that broad cannabis marketplace, the growing awareness and legalization efforts are expected to further propel the overall industry forward. In 2020, legal cannabis sales in the U.S were up 46% from 2019, reaching a new record of USD 17.5 Billion, according to cannabinoid market research firm BDSA.
Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO) just announced breaking news that,
"it is ramping up subject beta testing in a high-volume clinic in the Northwestern US and will ship an additional THC Breath Analyzer ("THCBA") unit to the site. The collaborating clinic has a robust drug testing operation and is one of the top drug testing providers to employers within its respective state. The Company also reports that it has shipped two THCBA devices to a biomedical clinic in southern Ontario for beta-testing.
The THCBA is a drug screening device for employers and other markets who are seeking a way to quickly (in less than 5 minutes), easily and non-invasively test for recent use of ∆9-tetrahydrocannabinol ("THC") - the psychoactive component of marijuana that causes impairment. The THCBA consists of a handheld device and protective case which houses a sterilization module, sample preparation stage, device recovery station and integrated battery charging system. Over the course of 2020 to present the Company has been relentlessly focused on building the THCBA from bench prototypes to the current hand-held portable version 3.0 system. Over recent months, this proof-of-concept system has been introduced into small scale beta-testing sites. The focus of the beta-testing has been to gather information on user and administrator experience, identifying cross-reactivity of other substances within a semi-controlled study population and to further collect data and train the device's machine learning database and sensitivity profile. Furthermore, feedback has been provided in areas of handling, connectivity, operating procedures and data management.
© 420 Intel
While most people can use marijuana without experiencing any issues whatsoever, fainting is a side effect that has been known to happen. Some medical experts say these blackout moments can occur since THC decreases blood pressure in the body.(As Originally Seen On Benzinga)
One second you’re at a party, laughing it up with friends like you’ve done a thousand times before when a joint makes its way into your hands. Nothing out of the ordinary here, except for the fact that by smoking with others, you are about to contract the germs of everyone else in the room, but that’s another story for another time. In this particular scenario, however, you take a hit off the joint, pass it to the left and continue to bask in the conversation going on around you.
But then all of a sudden, things start to get weird.
You might feel at first as if you are going to vomit, and your senses might start going a bit haywire. You might even have some trouble catching your breath, saying something to the person next to you, like “Dang, what was in that weed.” You even consider excusing yourself for a minute to regain your faculties, but before you have any chance to make it to the bathroom, everything goes black. You are told later that you just dropped out completely after taking that hit of weed.
Unfortunately, while most people can use marijuana without experiencing any issues whatsoever, fainting is a side effect that has been known to happen. Some medical experts say these blackout moments can sometimes occur since tetrahydrocannabinol (THC), the cannabinoid that produces the herb’s stoned effects, expands the blood vessels, which decreases blood pressure in the body. When this happens, the heart rate increases, and it can cause people to lose consciousness.
© 420 Intel
Cannabis Conference 2021, the industry’s leading event for plant-touching businesses, was host to nearly 3,000 cannabis professionals in August, who came together for the first time in two years to share the latest technologies and solutions, business strategies and more at Paris Las Vegas Hotel & Casino.
On the 85,000-square-foot trade show floor, 175 exhibitors showcased their products and services, while nearly 90 speakers shared their expertise during Cannabis Conference’s 40-plus session educational program. Sessions were jam-packed with business, cultivation, extraction and dispensary insights. After a monumental year in cannabis—there was much to discuss and break down.
© 420 Intel
More than six months after Texas legalized hemp, marijuana prosecution cases fell dramatically, with prosecutors filing fewer criminal charges while unleashing a struggle for police departments who now need to test substances in private labs, in order to prove illegal marijuana possession.
Since Gov. Greg Abbott signed the legalization of hemp at the beginning of June, focusing on agricultural practices and regulations, the number of misdemeanor marijuana possession cases dropped nearly two-thirds across Texas.
In 2018, Texas prosecutors filed about 5,900 new misdemeanor marijuana possession cases a month, as reported by the Texas Tribune, the first five months of 2019 saw an average of more than 5,600 new cases filed a month.
However, since June -when the hemp law was enacted- the number of cases has been slashed by more than half. In November, less than 2,000 new cases were filed, according to court data.
“In 2019, #txlege legalized hemp and threw into chaos the prosecution of marijuana crimes. From 2018 to 2019, pot possession arrests plummeted from 62.9k to 45.1k. In 2020, that number kept falling. @TxDPS reported 23.7k arrests statewide”. Reporter Jolie McCullough tweeted.
© 420 Intel
Copyright 2019 - 2024. WeedWorthy.com is a news division of MjLink.com, Inc.. All rights reserved. WeedWorthy
To contact the following departments, dial 1-844-420-4208 - Sales: Ext. #2 - Support: Ext. #3 - Investor Relations: Ext. #6
By using this website, you agree and understand that, by law: You MUST be at least 21 years of age to view any content on this website. To view the complete Terms of Use and Privacy Policy for this website, Click Here!
